Posted: July 28, 2016 at 7:45 am
Embryonic stem cells seen through a microscope. The study saw a 40% reduction in the size of scarred tissue on the patients hearts. Photograph: Mauricio Lima/AFP/Getty Images
People suffering from heart disease have been offered hope by a new study that suggests damaged tissue could be regenerated through a stem cell treatment injected into the heart during surgery.
The small-scale study, published in the Journal of Cardiovascular Translational Research, followed 11 patients who during bypass surgery had stem cells injected into their hearts near the site of tissue scars caused by heart attacks.
One of the trials most dramatic results was a 40% reduction in the size of scarred tissue. Such scarring occurs during a cardiac event such as a heart attack, and can increase the chances of further heart failure. The scarring was previously thought to be permanent and irreversible.
At the time of treatment, the patients were suffering heart failure and had a very high (70%) annual mortality rate. But 36 months after receiving the stem cell treatment all are still alive, and none have suffered a further cardiac event such as a heart attack or stroke, or had any readmissions for cardiac-related reasons.
According to the British Heart Foundation, while there are several treatments to help people with heart failure, there is no known cure, and in some cases a heart transplant may be the only option.
Twenty-four months after participants were injected with the stem cell treatment there was a 30% improvement in heart function, 40% reduction in scar size, and 70% improvement in quality of life, as judged by the Minnesota living with heart failure (MLHF) score.
Related: Brain damage could be repaired by creating new nerve cells
Quite frankly it was a big surprise to find the area of scar in the damaged heart got smaller, said Prof Stephen Westaby from John Radcliffe hospital in Oxford, who undertook the research at AHEPA university hospital in Thessaloniki, Greece, with Kryiakos Anastasiadis and Polychronis Antonitsis.
Westaby began theorising about the impact of stem cells on regenerating heart tissue and reducing scarring after observing how scar tissue on the hearts of babies who have had heart attacks and undergone heart failure disappeared by the time they reached adolescence, suggesting that residual stem cells might be able to repair the damaged tissue.
Its an early study and its difficult to make large-scale predictions based on small studies, said Ajan Reginald, the founder of Celixir, the company that produces the treatment. But even in a small study you dont expect to see results this dramatic.
These are 11 patients who were in advanced heart failure, they had had a heart attack in the past, multiple heart attacks in many cases. The life expectancy for these patients is less than two years, were excited and honoured that these patients are still alive.
Related: Nearly 2m people may have undiagnosed killer disease
Jeremy Pearson, the associate medical director at the British Heart Foundation (BHF), said: This very small study suggests that targeted injection into the heart of carefully prepared cells from a healthy donor during bypass surgery, is safe. It is difficult to be sure that the cells had a beneficial effect because all patients were undergoing bypass surgery at the same time, which would usually improve heart function.
A controlled trial with substantially more patients is needed to determine whether injection of these types of cells proves any more effective than previous attempts to improve heart function in this way, which have so far largely failed.
Westaby conceded that the improvement in patients health was partly due to the heart bypass surgery those in the study were undergoing, and said the next study would include a control group who undergo bypass but do not receive stem cell treatment, to measure exactly what impact the treatment has.
These patients came out of heart failure partly due to the bypass grafts of course, but we think it was partly due to the fact that they had a smaller area of scar [as a result of the stem cell treatment]. Certainly this finding of scar being reduced is quite fascinating, he said.
Westaby will commence a large-scale controlled study later this year at the Royal Brompton hospital in London, and Celixir hopes to make the Heartcel treatment available to patients in 2018 or 2019.
Read the original:
Stem cell trial suggests damaged heart tissue could be …
- Stem-cell screening finds statin alternative for hypercholesterolaemia - The Pharmaceutical Journal - April 27th, 2017
- UMN research team fixes broken hearts with 3D-printed tissue patch - Minnesota Daily - April 26th, 2017
- A 3D-printed patch for a 'broken' heart - Livemint - April 21st, 2017
- 3D-printed Patch Can Help Mend a 'Broken' Heart - Technology Networks - April 20th, 2017
- Outsourced Ion Channel Testing Trends - Technology Networks - April 18th, 2017
- Heart-healing patch has got the beat - New Atlas - April 18th, 2017
- First participant treated in trial of stem-cell therapy for heart failure - Medical Xpress - April 18th, 2017
- Scientists identify mechanisms of early heart development in Zebrafish - Biotechin.Asia - April 18th, 2017
- Regenexx Network Using Regenerative Medicine Technologies in Interventional Orthopedics to Treat Pain - OrthoSpineNews - April 18th, 2017
- 3D-Printed Patch Can Help Mend a 'Broken' Heart - Lab Manager | News (press release) (blog) - April 17th, 2017
- Regenexx Network Using Regenerative Medicine Technologies in Interventional Orthopedics to Treat Pain - Yahoo Finance - April 17th, 2017
- CESCA Therapeutics to Present at the 2017 International Symposium of Translational Medicine in Stem Cell ... - GlobeNewswire (press release) - April 17th, 2017
- Scientists have made a 3D-printed patch that can help heal the damaged heart tissue - Tech2 (blog) - April 16th, 2017
- Breakthrough in cardiac health: 3D-printed patch can help mend a 'broken' heart - Economic Times - April 15th, 2017
- SPECTRUM Drug Screen Reveals Fox Gloves Can Treat High Cholesterol - Technology Networks - April 15th, 2017
- Successful Interim Analysis of Efficacy Endpoint in Mesoblast's Phase 3 Trial for Chronic Heart Failure - GlobeNewswire (press release) - April 13th, 2017
- Multipotent vs. pluripotent stem cells - Pathology Student - April 12th, 2017
- CESCA Therapeutics to Present at the 2017 International Symposium of Translational Medicine in Stem Cell ... - Yahoo Finance - April 12th, 2017
- Therapists receive continuing education - Twin Falls Times-News - April 11th, 2017
- Stem cells may provide lasting treatment for HF - Healio - April 9th, 2017
- Can An Artificial Thymus, Made from Stem Cells, Pump Out Enough T-Cells To Fight Cancer? - Dispatch Tribunal - April 9th, 2017
- How cells react to injury from open-heart surgery: Research ... - Science Daily - April 8th, 2017
- TiGenix reports 2016 full year results | P&T Community - P&T Community - April 6th, 2017
- Study: heart failure stem cell therapy safe, shows early signs of effectiveness - The San Diego Union-Tribune - April 6th, 2017
- First Ph.D. recipient - UDaily - April 5th, 2017
- Stem Cells in Drug Discovery | Technology Networks - Technology Networks - April 5th, 2017
- Stem Cells: Viable Option for CHF or Pipe Dream? | Medpage ... - March 31st, 2017
- Therapeutic microparticles functionalized with biomimetic ... - March 31st, 2017
- Cardiac Stem Cells Offer New Ways to Prevent and Treat ... - March 31st, 2017
- VistaGen Therapeutics Receives European Patent Office Notice of Intention to Grant European Patent for AV-101 - Yahoo Finance - March 31st, 2017
- Heart tissue grown on spinach leaves: Researchers turn to the ... - Science Daily - March 28th, 2017
- Researchers Turn Spinach Leaves Into Beating Heart Tissues - Smithsonian - March 28th, 2017
- Human heart muscle made from stem cells - Free Press Journal - March 26th, 2017
- Measuring Heart Toxicity of Cancer Drugs | Technology Networks - Technology Networks - March 24th, 2017
- Pathologists and Clinical Laboratories May Soon Have a Test for Identifying Cardiac Patients at Risk from Specific ... - DARKDaily.com - Laboratory... - March 23rd, 2017
- 'Beating' Heart Created from Stem Cells - Technology Networks - March 22nd, 2017
- Stem Cell Cardiac Toxicity Model for Testing Chemotherapy Agents - Technology Networks - March 21st, 2017
- Self-repairing heart tissue breakthrough brings hope for cardiac patients - ABC Online - March 16th, 2017
- Scientists create 'beating' human heart muscle for cardiac research - UQ News - March 16th, 2017
- Belgium's Tigenix says heart attack stem cell trial successful - Reuters - March 15th, 2017
- Cardiac researcher Milica Radisic to present keynote address at Libin Institute's Cardiac Research Day - UCalgary News - March 15th, 2017
- Daiichi Sankyo forges $12M pact for GPCR pain program with Heptares; Incyte shares jump on latest takeover chatter - Endpoints News - March 14th, 2017
- Woodrose Ventures Corporation Announces Proposed Acquisition ... - Marketwired (press release) - March 14th, 2017
- TiGenix Announces Top-Line Phase I/II Results of AlloCSC-01 in Acute Myocardial Infarction - GlobeNewswire (press release) - March 14th, 2017
- Belgium's Tigenix says heart attack stem cell trial successful - KFGO - March 13th, 2017
- TiGenix Announces Top-Line Phase I/II Results of AlloCSC-01 in Acute Myocardial Infarction - P&T Community - March 13th, 2017
- VistaGen Therapeutics Inc. (Nasdaq: VTGN) to Ring The Nasdaq ... - GlobeNewswire (press release) - March 10th, 2017
- Cardiac research nets Holly Mewhort prestigious heart association award - UCalgary News - March 10th, 2017
- TiGenix Announces Positive Topline Week-104 Data for Cx601 ADMIRE-CD Trial - P&T Community - March 10th, 2017
- Robert Clayton Robbins Top Choice for UA President - Arizona Public Media - March 9th, 2017
- Mountain News: Clinic advances stem-cell research - Pique Newsmagazine - March 9th, 2017
- Stem Cell Therapy receives FDA Boost to enter the US Market - Labiotech.eu (blog) - March 8th, 2017
- Using Stem Cells to Predict Toxicity of Chemotherapy Drugs ... - ScienceBlog.com (blog) - March 6th, 2017
- Student profile: Keegan Mendez - Harvard School of Engineering and Applied Sciences - March 6th, 2017
- Opinion/Commentary: Global stem cell therapy market to showcase ... - The Daily Progress - March 5th, 2017
- Stem cell therapy can help in treating diabetic heart disease - Business Standard - March 4th, 2017
- Stem cell therapy can help treat diabetic heart disease - Economic Times - March 1st, 2017
- Johns Hopkins Medicine, Maryland Stem Cell Research Fund and ... - Business Wire (press release) - March 1st, 2017
- StemBioSys Lands Experimental UT Tech That Finds Young Stem Cells - Xconomy - March 1st, 2017
- TiGenix to present at Cowen's 37th Annual Health Care Conference in Boston - EconoTimes - March 1st, 2017
- Stem cell therapy can help in treating diabetic heart disease - India.com - February 28th, 2017
- Canadian Pacific makes a $1 million gift to fund stem cell research at the CHU Sainte-Justine - New hope for ... - Canada NewsWire (press release) - February 28th, 2017
- Heart failure BREAKTHROUGH: Stem cells trial offers hope to millions - Express.co.uk - February 25th, 2017
- Cardiac injury, recovery is topic of Osher lecture - Stowe Today - February 24th, 2017
- Nanostraw doesn't destroy cells as it samples their guts - Futurity - Futurity: Research News - February 24th, 2017
- Less Acute MI, More HF: European Task Force Shifts Support for 'Overhyped' Cell Therapy Research - TCTMD - February 22nd, 2017
- Nanostraws Sample Cells Without Damage - R & D Magazine - February 22nd, 2017
- CardioBrief: After Yet Another Failure, Stem Cell Leaders Double Down - MedPage Today - February 21st, 2017
- Minuscule nanostraws sample a cell's contents without damage ... - Stanford University News - February 21st, 2017
- Researchers implicate suspect in heart disease linked to diabetes - Medical Xpress - February 21st, 2017
- Cardiac Muscle Cells Create Living Diode - Controlled Environments Magazine - February 16th, 2017
- Scientists create scorecard index for heart-damaging chemo drugs - Medical Xpress - February 16th, 2017
- Researchers develop 'living diode' using cardiac muscle cells - Science Daily - February 15th, 2017
- VistaGen Therapeutics Reports Fiscal Third Quarter 2017 Financial ... - Yahoo Finance - February 13th, 2017
- Stem Cell Basics VI. | stemcells.nih.gov - February 10th, 2017
- Myocardial Stem Cell Patch Developed with 3D Printer - BusinessKorea - February 10th, 2017
- Function of olfactory receptor in the human heart identified - Medical Xpress - February 8th, 2017
- Regrowing heart muscles without cancer risk, using synthetic stem cells - Genetic Literacy Project - February 7th, 2017
- World Stem Cell Summit - December 23rd, 2016
- Induced stem cells - Wikipedia - November 29th, 2016